Skip to content
Conference Open access

Glycometabolism and Fructose-1,6-bisphosphatase Deficiency Disease

2026 · BIO Web of Conferences · 0 citations · 26 references

Abstract

Fructose-1,6-bisphosphatase (FBP) deficiency disease is a rare autosomal recessive inherited metabolic disorder. It has defects in key enzymes of the liver gluconeogenesis pathway caused by FBP1 gene mutation of Zone q22 in the chromosome 9#. Since FBP is the last step of rate-limiting enzyme of gluconeogenesis, deficiency of FBP will cause hypoglycemia, lactic acidosis and metabolic disorder, and this disorder might be intensified under fasting or stress state. It is reported in Italy that the incidence rate is about 1/147,575 and FBP deficiency has been reported around the world. The initial onset commonly occurs in infancy, presenting as acute hypoglycemia triggered by fasting or infection, accompanied by metabolic acidosis, tachypnea, and hepatomegaly. The diagnosis depends on clinical manifestation, blood biochemical test (hypoglycemia with hyperlactacidemia), leukacytic ferment activity test or FBP1 gene analysis, and it shall be distinguished from other diseases like epilepsy. At present, treatment focuses on correcting the metabolism disorder at the acute stage and long-term dietary management, strictly avoiding fasting state and fructose / sorbitol intake. With the development of gene therapy technology, FBP deficiency might be able to be cured by FBP1 gene replacement based on AAV vector, enzyme replacement therapy and CRISPR gene editing. However, these strategies are challenged by delivery efficiency, immunogenicity and clinical translation. Future researches can expand newborn screening, development of targeting FBP1 activator and optimizing the safety of gene therapy. This review systematically synthesizes recent progress in understanding the pathogenesis, glucose metabolism dysregulation, and treatment strategies for FBP deficiency. Research results provide theoretical references to diagnosis and treatment of rare metabolic disorders.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.